Menu
← Oncology Approval Tracker
FDA DECISION ·
Bortezomib for Injection (Hospira)
bortezomib · Hospira
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adult mantle cell lymphoma added to the label for the specified Hospira bortezomib-for-injection product.
LAMPGEN ANALYSIS
Why it matters
The decision extends the labeled use of this product to a second hematologic malignancy.
What research teams should watch
Record the product identity and diagnosis when incorporating the additional indication into ordering workflows.
PRIMARY RECORDS